Chemical modification of the nucleosides that comprise tRNAs are diverse 1-3 . Such modifications impact 16 tRNA structure, stability, and mRNA decoding 3,4 . Although tRNA modifications are present in all 17 kingdoms of life 1 , the structure, location, and extent of modifications have been systematically charted 18 in very few organisms, in part because mapping modifications to tRNA sequences has been technically 19 challenging. Here, we describe a new approach in which rapid prediction of modified sites through 20 reverse transcription-derived signatures in high-throughput tRNA-sequencing (tRNA-seq) data is 21 coupled with chemical analysis and identification of tRNA modifications through RNA mass 22 spectrometry (tRNA-SMS). As proof of concept, we applied this method to study tRNA modification 23 profiles in two phylogenetically close bacteria, E. coli and Vibrio cholerae. Comparative tRNA-seq 24 enabled prediction of several V. cholerae modifications that are absent from E. coli and showed the 25 effects of various environmental conditions on V. cholerae tRNA modification profiles. Through RNA 26 mass spectrometric analyses, we showed that two of the V. cholerae-specific reverse transcription 27 signatures reflected the presence of a new modification (acetylated acp 3 U (acacp 3 U)), while another 28 results from C-to-U RNA editing, a process not described before in bacteria. By combining comparative 29 genomics with mass spectrometry, we identified a putative N-acetyltransferase required for acacp 3 U 30 acetylation. These findings demonstrate the utility of the tRNA-SMS approach for rapid characterization 31 of tRNA modification profiles and environmental control of tRNA modification. Moreover, our 32 identification of a new modified nucleoside and RNA editing process suggests that there are many tRNA 33 modifications awaiting discovery. 34
derived signatures can be used to profile many tRNA modifications. 48
Next, we applied tRNA-seq to define tRNA modification profiles in an organism where tRNA 49 modifications have not been characterized: Vibrio cholerae, the cholera pathogen. Analysis of tRNA-seq 50 data from stationary phase V. cholerae samples yielded heatmaps of misincorporation and termination 51 similar to those of E. coli (Fig. 1 ). This observation is consistent with the conservation of most E. coli 52 tRNA modification enzymes in V. cholerae (Supplementary Data 2). The identity of modifications 53 introduced by thiI, ttcA, and miaA (s 4 U, s 2 C, and ms 2 io 6 A, respectively) was confirmed by analyzing tRNA 54 from strains lacking these enzymes ( Supplementary Fig. 3A-C) . 55
We observed several misincorporation signals in V. cholerae that were not present in E. coli, 56
including at A22 and C32 in tRNA-Tyr, U20B in tRNA-Glu, U46 in tRNA-Gln1A, Gln1B and Gln1C, G6 in 57 tRNA-Leu1B, C35 in tRNA-Arg2A and A63 in tRNA-fMetC ( Fig. 1) . U20B in tRNA-Glu and U46 in tRNA-58
Gln1ABC were also associated with increased termination of reverse transcription (Fig. 1) . In other 59 bacteria, e.g., B. subtilis, A22 is methylated to m 1 A by TrmK in a subset of tRNAs 7,8 ; consequently, we 60 samples derived from the cecal fluid of infant rabbits infected with the pathogen 9 . The resulting 73 misincorporation and termination signatures were similar to those of log phase samples 74 ( Supplementary Fig. 4B vs. 4A), including modification at position 47 ( Fig. 2A) . Thus, tRNA-seq enables 75 assessment of tRNA modification profiles under a variety of conditions. 76
We hypothesized that RT signatures found in V. cholerae but not E. coli (Fig. 1AB ) could reflect V. 77 cholerae-specific modifications, and used RNA mass spectrometric analysis to identify the chemical 78 moieties at some of these positions, focusing initially on U20B in tRNA-Glu and U46 in tRNA-Gln1B. 79
Nucleoside analyses, which reveal the composition of modified ribonucleosides in each tRNA, were 80 carried out on purified tRNA-Glu and tRNA-Gln1B, and revealed that tRNA-Glu contains , mnm 5 s 2 U, T 81 and Gm, while tRNA-Gln1B contains D, , cmnm 5 s 2 U, T, s 4 U and m 2 A ( Supplementary Fig. 3A and 82
Supplementary Data 3). In addition, these analyses showed that tRNA-Glu and tRNA-Gln1B both also 83 possesses a ribonucleoside whose molecular weight is 387 ( Fig. 3A, Supplementary Fig. 6 ). Since no 84 known modified ribonucleoside has a mass of 387 2 , we postulated that this nucleoside (designated 85 N387) is a novel modification that may be incorporated at various sites (e.g., U20B or U46) within 86 tRNAs. To confirm the positions of N387, we performed fragment analyses. N387-containing fragments 87
were detected using MALDI-TOF mass spectrometry of tRNAs digested with RNase A, which cleaves at 88 the 3' end of C and U, or RNase T 1 , which cleaves at the 3' end of G ( Fig. 3A and Supplementary Fig. 7) . 89
RNase A digests revealed fragments of m/z 2121.7 in tRNA-Glu and 1431.1 in tRNA-Gln1B, consistent 90 with the location of N387 at U20B and U46 in these tRNAs, respectively (Fig. 3A) . These results suggest 91 that the V. cholerae-specific misincorporation signals in tRNA-Glu and tRNA-Gln1B result from N387. 92
High-resolution mass spectrometric analysis of N387 from tRNA-Glu yielded a mass value of 93 387.1273; the best matched chemical formula 10 corresponding to this mass value is C15H21N3O9 ( Fig.  94 3B). This formula is close to that of acp 3 U (C13H19N3O8), with the difference in chemical composition 95 between these compounds corresponding to acetylation (C2H2O). Since acp 3 U contains a primary 96 amine, a plausible target of acetylation, we predicted that N387 is acetylated acp 3 U, i.e., 3-(3-97 acetamidecarboxypropyl)uridine (acacp 3 U). MS/MS analysis with acp 3 U and N387 was used to test this 98 hypothesis. The product ions of acp 3 U, e.g., m/z 56, 168 and 214, were also observed in the spectrum of 99 N387, consistent with the presence of acp 3 U in the structure of N387 ( Fig. 3C ). Several additional 100 fragment ions (e.g., m/z 238 and 210) further corroborate the proposed structure of N387 as acacp 3 U. 101 MS/MS spectra of N387 were nearly identical in tRNA-Gln1A and tRNA-Gln1B ( Supplementary Fig. 8) , 102
suggesting that these tRNAs also contain acacp 3 U. 103 A comparative genomics approach was then used to identify an acetyltransferase that is required 104 for acacp 3 U formation. We analyzed total tRNA from bacterial species that are phylogenetically close to 105 V. cholerae (Vibrio parahaemolyticus, Aeromonas hydrophila, and Shewanella oneidenis), and found that 106 V. parahaemolyticus contains acacp 3 U but the other bacteria do not ( Fig. 3D and Supplementary Fig. 9 ). coli ( Fig. 3D and Supplementary Data 4). Nucleoside analysis of total tRNA from transposon insertion 111 mutants corresponding to each of these 5 loci 12 detected a decreased acacp 3 U signal and an increased 112 acp 3 U signal in tRNA from vc0317::Tn ( Supplementary Fig. 10 ). Furthermore, analysis of tRNA from an 113 in-frame vc0317 deletion mutant revealed that disruption of vc0317 abolished the acacp 3 U signal and 114 increased the acp 3 U signal ( Fig. 3E ). Collectively, these results strongly suggest that vc0317 mediates 115 acetylation during acacp 3 U synthesis and we renamed vc0317 as acpA (for acp 3 U acetylation). Notably 116 in PFAM 13 , acpA is predicted to encode an N-acetyltransferase, providing further support for the idea 117 that N387 includes acetylation of a primary amine group. One effect of acetylation of acp 3 U involves 118 tRNA abundance, with modestly reduced tRNA-Gln1A levels in log phase cultures of acpA compared to 119 the wild type strain ( Fig. 3F ). 120 V. cholerae tRNA-seq analysis also revealed a high misincorporation frequency at C32 in tRNA-Tyr 121 ( Fig. 1A) . Most sequencing reads contained U rather than C at position 32, even though C is present in 122 all 5 copies of this tRNA gene 14 ( Supplementary Fig. 11 ). RT-PCR coupled with direct Sanger sequencing 123 confirmed the presence of this C-to-U conversion in tRNA-Tyr ( Fig. 4A ). However, ribonucleoside and 124 fragment analysis of purified tRNA-Tyr did not detect any modifications that could be assigned to 125 position 32, although it successfully assigned several other modifications ( Fig. 4B , Supplementary Fig.  126 12). Instead, fragment analysis revealed a U32-containing fragment (AGAUp, m/z 1326.25) ( Fig. 4C) , 127 strongly suggesting that C32 undergoes post-transcriptional C-to-U RNA editing. Intriguingly, tRNA-Tyr 128 from a strain lacking miaA, which is responsible for the initial step of biosynthesis of ms 2 io 6 A at position 129 37 in tRNA-Tyr, retains C at position 32 ( Fig. 4AC ). tRNA-Tyr from a strain lacking thiI, whose product 130 synthesizes s 4 U at position 8 and 9 in tRNA-Tyr, contained both C and U at position 32 ( Fig. 4A ). These 131 results suggest that C-to-U editing at this site depends upon the presence of other modification(s) or the 132 associated modification enzymes. The enzyme responsible for C-to-U RNA editing in V. cholerae remains 133 unknown. Since T. brucei's A-to-I editing enzyme is reported to catalyze C-to-U editing as well 15 , it is 134 possible that VC0864, V. cholerae's presumed A-to-I tRNA editing enzyme, could also be involved in C-135 to-U editing 136
Our findings demonstrate that comparative tRNA-seq provides a high-throughput method for 137 cataloging sites of likely tRNA modification and identifying tRNA species or conditions warranting more 138 in-depth analyses. By combining tRNA-seq and RNA mass spectrometry (tRNA-SMS) to characterize V. 139 cholerae's tRNA, we uncovered a species-specific modification (m 1 A) and discovered a new tRNA 140 modification (acacp 3 U) along with an enzyme required for its synthesis. Moreover, this approach 141 yielded evidence of C-to-U RNA editing, a process not previously observed in bacteria. Thus, our data 142 reveals substantial diversity in tRNA modifications among even phylogenetically closely related 143 organisms like V. cholerae and E. coli. Since the full complement of tRNA modifications have been well 144 characterized in only a few model organisms, e.g., E. coli and Saccharomyces cerevisiae, it is likely that 145
there is a plethora of as yet undescribed modifications. The tRNA-SMS approach should be useful to 146 probe the diversity of tRNA modifications throughout all three kingdoms of life.
Methods 148

Strains and culture conditions 149
The strains used in this study are listed in Supplementary Table 2 . V. cholerae C6706, a clinical 150 isolate 16 , and E. coli MG1655 were used in this study as wild-type strains. All V. cholerae, E. coli, and V. 151 parahaemolyticus strains were grown in LB containing 1 % NaCl at 37 C. E. coli SM10 (lambda pir) 152 harboring derivatives of pCVD442 17 was cultured in LB plus carbenicillin (Cb). Antibiotics were used at 153 the following concentrations: 200 g/mL streptomycin, 50 g/mL Cb. Aeromonas hydrophila and 154
Shewanella oneidensis were cultured at 30C in nutrient broth (BD) and Tryptic Soy Broth, respectively. Supplementary Table 1 ) were used to 210 assign modifications to the E. coli tRNA-seq data in Supplementary Figure 2 . Misincorporation 211 frequencies of > 5% at sites of modification in the reference database were used as a threshold for 212 assignment of predicted modifications. Termination frequencies of >5% were also used as a threshold 213 for assignments of modified sites; however, since termination signals were usually detected two 214 nucleotides downstream from known modified sites, assignments were adjusted accordingly (except 215 for DD, acp 3 U, k 2 C, and m 6 t 6 A (see Supplementary Table 1) ). E. coli modifications were considered to be 216 predictable when signals (either of misincorporation or termination) were present in  50% of known 217 modified sites. 218 V. cholerae modifications were also assigned with >5% thresholds for misincorporation or 219 termination. Although G at position 10 (G10) in several tRNAs and G at position 35 (G35) in tRNA-Leu2 220 have misincorporation signals greater than 5%, they were excluded from further analysis because these These elevated misincorporation signals may arise from other factors including residual secondary or 223 tertiary structures or specific sequence contexts influencing reverse transcription. Dynamic multiple reaction monitoring (MRM) was carried out to survey known modifications. In 251 the first quadrupole, a proton adduct of a target nucleoside was selected as a precursor ion based on its 252 mass to charge ratio (m/z). Only singly charged ions, i.e., z equals 1, were observed. In the second 253 quadrupole, the precursor was broken by collision inducible dissociation (CID) to produce nucleoside 254 species specific product ions, which in many cases were proton adducts of different bases. Then, one 255 specific product ion was selected in the third quadrupole based on its m/z value and delivered to the The neutral loss scan (NLS) method was used to search for unknown modifications. For one run, 260
we used ~50 mass values of precursor ions with 1 Da intervals. Then, a mass of the product ion was set 261 132 Da lower than that of the precursor ion, a value corresponding to the loss of a ribose moiety. We 262 performed five runs to cover precursor ions whose m/z values ranged from 244 to 445 (Supplementary 263 Fig. 6 ). The presence of N387 was then confirmed by MRM analysis. 264
For MS/MS analysis, 1 g of isolated tRNAs were hydrolyzed. In this analysis, we selected singly-265 protonated ions with m/z 388 for N387 and 346 for acp 3 U as precursor ions in the first quadrupole, 266 respectively; after CID in the second quadrupole, an m/z scan from 10 to 1000 was carried out in the 267 third quadrupole, yielding the mass spectra of the fragments. 268
To measure the mass of N387 precisely, 2.5 g of tRNA-Glu was digested as described above and 269 500 ng of the digest was subjected to the HPLC system described above coupled with an Agilent 6520 270 to 90 C for 1 min and gradually cooled down to room temperature at 1 C/min for annealing, followed 287 by RNase digestion with 50 ng RNase A and 50 unit RNase T 1 on ice for 15 min. Protected DNA/RNA 288 duplexs were purified on 10 % TBE-Urea gels and recovered by isopropanol precipitation and dissolved 289 in 5 l milliQ. A 2 l aliquot was subjected to fragment analysis with RNase A using a MALDI-TOF 290 spectrometer as described above. 291 292 Comparative genomics 293 seven V. cholerae proteins that include "acetyltransferase" in their COG names were retrieved from COG 298 2003-2014 update using R 11 . Five of these putative acetyltransferases were found to be present in V. 299 cholerae and V. parahaemolyticus, but not in A. hydrophila, S. oneidenis and E. coli when 1E-10 was used 300 as a threshold. 301 302
Infant rabbit infection 303
Mixed-gender litters of 2 day old New Zealand white infant rabbits, cohoused with a lactating 304 mother (Charles River) were inoculated with wild-type V. cholerae as described 9 . Approximately 20hr 305 post-inoculation, the rabbits were sacrificed and V. cholerae in the cecal fluid was collected by 306 centrifugation. Total RNA was then extracted using TRIzol reagent. 
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